Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CTXR — Citius Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in CTXR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$33,154
+$23,133 QoQ
Shares Held
36,838
+185.6% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 38 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CTXR Over Time

Shares Held

Position Value (USD)

Derivatives in CTXR

reported options exposure · as of Dec 31, 2025
CallValue
$52,913
CallShares
68,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. CTXR ranks #331 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTXR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $33,154 36,838
2025-12-31 $52,913 68,100
2025-12-31 $10,021 12,898
2025-09-30 $59,750 48,186
2025-09-30 $28,272 22,800
2025-06-30 $29,256 18,400
2025-06-30 $21,147 13,300
2025-06-30 $22,576 14,199
2024-12-31 $215,200 53,800